Compare BIO & RMBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | RMBS |
|---|---|---|
| Founded | 1952 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Semiconductors |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 10.5B |
| IPO Year | 1994 | 1997 |
| Metric | BIO | RMBS |
|---|---|---|
| Price | $361.29 | $84.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $335.00 | $140.57 |
| AVG Volume (30 Days) | 212.7K | ★ 1.8M |
| Earning Date | 11-04-2026 | 10-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 142.61 | 27.88 |
| EPS | N/A | ★ 1.84 |
| Revenue | ★ $2,583,200,000.00 | $707,630,000.00 |
| Revenue This Year | N/A | $18.48 |
| Revenue Next Year | $2.13 | $20.50 |
| P/E Ratio | ★ N/A | $45.81 |
| Revenue Growth | 0.65 | ★ 27.13 |
| 52 Week Low | $236.73 | $77.89 |
| 52 Week High | $396.23 | $174.10 |
| Indicator | BIO | RMBS |
|---|---|---|
| Relative Strength Index (RSI) | 45.72 | 38.21 |
| Support Level | $350.29 | $81.38 |
| Resistance Level | $391.87 | $104.44 |
| Average True Range (ATR) | 11.53 | 5.23 |
| MACD | 1.14 | -1.07 |
| Stochastic Oscillator | 38.10 | 12.98 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Rambus Inc is a semiconductor company providing chips and silicon IP for data-intensive computing systems, focusing on data center and artificial intelligence (AI) infrastructure. The company is at the forefront of enabling the next era of AI-driven computing, addressing challenges of signal and power integrity at increasingly extreme data rates across the data center, edge, and client markets. It offers high-performance memory subsystems, with a balanced and diverse portfolio of products, IP, and patents that maximize performance and security in computationally intensive systems. The company operates in South Korea, Singapore, the United States, and other countries, with the majority of its revenue coming from South Korea.